73 completed, 12 unknown, 1 terminated. 30 Phase 1, 25 Phase 3, 11 Phase 2, 10 Not applicable, 8 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 30 | Completed 28, Unknown 2 |
| Phase 3 | 25 | Completed 20, Unknown 4, Terminated 1 |
| Phase 2 | 11 | Completed 8, Unknown 3 |
| Not applicable | 10 | Completed 9, Unknown 1 |
| Phase 4 | 8 | Completed 7, Unknown 1 |
Follow LG Life Sciences: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Trial to Evaluate the Efficacy and Safety of Gemigliptin Compared With Placebo Added on Insulin Alone or on Insulin in Combination With Metformin in Type 2 DM (ZEUS II Study) Gemigliptin, Gemigliptin placebo, Metformin - Type 2 Diabetes Mellitus | Phase 3 | Completed | LG Life Sciences | 290 | 2016-10-17 | 2018-02-22 |
| To Compare and Evaluate the Efficacy and Safety of Ganilever PFS(Prefilled Syringe) and Orgalutran® Ganirelix acetate - Controlled Ovarian Stimulation | Phase 4 | Completed | LG Life Sciences | 255 | 2016-10-01 | 2019-07-02 |
| A Phase I Clinical Trial of a 13-valent Pneumococcal Conjugate Vaccine and 14-valent Pneumococcal Conjugate Vaccine in Adults Pneumococcal conjugate vaccine - Pneumococcal Infections | Phase 1 | Completed | LG Life Sciences | 63 | 2016-09-01 | 2017-06-26 |
| Evaluation of the Ease of Use, Preference, and Safety of EutropinPen Inj. Somatropin - Short Stature, Idiopathic, Infant, Small for Gestational Age | Phase 4 | Completed | LG Life Sciences | 116 | 2016-08-11 | 2019-01-03 |
| A Study Comparing LBAL to Humira® in Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therapy LBAL, Humira® - Arthritis, Rheumatoid | Phase 3 | Completed | LG Life Sciences | 383 | 2016-04-13 | 2021-03-15 |
| A Study to Evaluate the Long-term Safety and Efficacy of LBEC0101 in Subjects With Active RA Despite Methotrexate (MTX) LBEC0101 - Rheumatoid Arthritis | Phase 3 | Completed | LG Life Sciences | 148 | 2016-04-01 | 2018-07-06 |
| Study to Evaluate the Efficacy, Safety and PK of Intravenous Single Injection LC28-0126 Immediately Before PCI in STEMI Patients Placebo, LC28-0126 Dose A, LC28-0126 Dose B - ST-segment Elevation Myocardial Infarction | Phase 2 | Unknown | LG Life Sciences | 100 | 2016-04-01 | 2016-05-12 |
| BE Study of the Combinations of Gemigliptin 50mg and Rosuvastatin 20mg in Comparison to Each Component Administered Alone gemigliptin 50mg, rosuvastatin 20mg - Healthy | Phase 1 | Unknown | LG Life Sciences | 37 | 2016-03-01 | 2016-05-11 |
| BE Study of the Combinations of Gemigliptin 50mg and Metformin HCl Extended Release 2000mg in Comparison to Each Component Administered Alone gemigliptin and metformin HCl extended release, gemigliptin/metformin HCl extended release - Healthy | Phase 1 | Unknown | LG Life Sciences | 25 | 2015-08-01 | 2016-02-02 |
| Extension Clinical Study to Evaluate the Long-term Efficacy and Safety of Repeat Treatment of YVOIRE Contour Injected Into the Anteromedial Malar Region in Subjects Who Have Completed the LG-HACL014 Study YVOIRE contour - Normal, Healthy Adults With Moderate, Severe, or Very Severe Volume Loss of Anteromedial Malar Region Who Have Completed the LG-HACL014 Study | Not applicable | Completed | LG Life Sciences | 13 | 2015-05-01 | 2018-11-09 |
| Observational Study to Evaluate Long-term Safety and Biodegradability of YVOIRE Volume s YVOIRE volume s - Correction of Nasolabial Folds | Completed | LG Life Sciences | 503 | 2015-05-01 | 2019-03-19 | |
| Bioequivalence of a Single Subcutaneous Dose of BEPO and REPO in Healthy Male Subjects BEPO-A, REPO-A - Healthy | Phase 1 | Completed | LG Life Sciences | 46 | 2015-04-01 | 2016-03-18 |
| Post-authorization Safety Study of Euforvac-Hib Vaccine for Active Primary Immunization in Infants From 6 Weeks Diphtheria, Tetanus | Unknown | LG Life Sciences | 3000 | 2015-03-01 | 2014-10-07 | |
| A Study Comparing LBEC0101 to Enbrel® in Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therapy Enbrel, LBEC0101 - Arthritis, Rheumatoid | Phase 3 | Unknown | LG Life Sciences | 372 | 2015-02-01 | 2016-01-06 |
| Effects of DPP4 Inhibitor on Cisplatin Induced Acute Kidney Injury Gemigliptin, Placebo, Cisplatin - Cancer, Cisplatin Adverse Reaction | Phase 2 / Phase 3 | Unknown | Seoul National University Bundang Hospital | 182 | 2014-12-01 | 2016-04-20 |
| BE Study of the Combinations of Gemigliptin 50mg and Metformin HCl Extended Release 500mg in Comparison to Each Component Administered Alone gemigliptin and metformin HCl extended release, gemigliptin/metformin HCl extended release - Healthy | Phase 1 | Completed | LG Life Sciences | 29 | 2014-12-01 | 2015-02-03 |
| Observational Study to Evaluate Long-term Safety and Biodegradability of YVOIRE Classic s YVOIRE Classic s - Correction of Nasolabial Folds | Completed | LG Life Sciences | 503 | 2014-09-01 | 2019-03-13 | |
| Erythropoietin Therapy for Children With Cerebral Palsy Erythropoietin, Placebo erythropoietin - Cerebral Palsy | Phase 2 | Completed | Bundang CHA Hospital | 11 | 2014-09-01 | 2017-10-12 |
| Pharmacokinetics and Safety Study of LBAL in Healthy Subjects LBAL, Humira - Healthy Subjects | Phase 1 | Completed | LG Life Sciences | 116 | 2014-08-01 | 2015-06-15 |
| Effect of Gemigliptin on Metabolic Endotoxemia and Lipemia Gemigliptin, Placebo - Type 2 Diabetes Mellitus | Not applicable | Completed | Seoul National University Hospital | 10 | 2014-07-01 | 2016-04-21 |
Showing 20 of 86. Sign in to see all of them.
Diabetes Mellitus, Type 2 (11) · Dwarfism, Pituitary (6) · Hypertension (5) · Arthritis, Rheumatoid (3) · Cerebral Palsy (3) · Hepatitis B, Chronic (3) · Hyperlipidemias (3) · Communicable Diseases (2) · Diabetes Mellitus (2) · Hepatitis B (2) · Obesity (2) · Osteoarthritis, Knee (2) · Pituitary Diseases (2) · ST Elevation Myocardial Infarction (2) · Vomiting (2)
LC15-0444 (22) · LBEC0101 (4) · Metformin (4) · Rosuvastatin Calcium (4) · Valsartan (4) · ((1-((2-amino-9H-purin-9-yl)methyl)cyclopropyl)oxy)methylphosphonic acid dipivoxyl (3) · Etanercept (3) · Human Growth Hormone (3) · Adalimumab (2) · Diet, Fat-Restricted (2) · Erythropoietin (2) · Growth Hormone (2) · HibTITER protein, Haemophilus influenzae (2) · Sitagliptin Phosphate (2) · Sugar-Sweetened Beverages (2)
South Korea (65) · China (4) · Denmark (2) · Japan (2) · United States (2) · Germany (1)
Kyung-Sang Yu, M.D., Ph.D. (3) · HJ Ji, PhD (2) · Kyung Sang Yu, MD, PhD (2) · Kyung-sang Yu, M.D,Ph.D (2) · Minyoung Kim, M.D., Ph.D. (2) · BW Lee (1) · Ching-Lung Lai, Dr (1) · Der-Sheng Sun, MD,PhD (1) · Dong Bok Shin, MD, PhD (1) · Ference Peter, MD (1) · Hoon-Kyo Kim, MD,PhD (1) · In-Sook Woo, MD,PhD (1) · JH Jo (1)
PMID 20091678, PMID 22245607, PMID 25350224, PMID 17302367, PMID 18808318, PMID 19223649, PMID 22192641, PMID 22205311, PMID 22252107, PMID 22534255, PMID 22981147, PMID 24092928, PMID 24170106, PMID 24627290, PMID 25450470, PMID 25465680, PMID 25678778, PMID 26021829, PMID 26081486, PMID 26164786, PMID 27191767, PMID 28549436, PMID 28551775, PMID 29259050, PMID 30288156, PMID 31113455, PMID 31511031, PMID 31908426, PMID 33149182, PMID 33246489, PMID 36118751